#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neuroendocrine tumour Niemann-Pick disease Glycogen storage disease type I Arginase deficiency Undifferentiated sarcoma Cutaneous T-cell lymphoma stage II Parkinson's disease Arteriosclerosis Nephropathy Familial amyotrophic lateral sclerosis Hyperoxaluria Neoplasm Diffuse large B-cell lymphoma Trigeminal neuralgia Fibrodysplasia ossificans progressiva More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Treatment KBG syndrome Ornithine transcarbamoylase deficiency Metachromatic leukodystrophy Breast angiosarcoma – Treatment Loeys-Dietz syndrome – Treatment Retinitis pigmentosa – Life with Disease Stevens-Johnson syndrome Retinoblastoma – Life with Disease Lennox-Gastaut syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dextromethorphan Hydrobromide Cladribine Deoxyribonucleic Acid F1245/05 Ulotaront Tumour Detection Gs-5245 Levoleucovorin Disodium Medi0618 LY3848575 Emedastine Carcik-Cd19 Cells Interleukin-2 Ep0042 Iclepertin Lacutamab Dorocubicel Lu Ag09222 Tapderimotide ENSIFENTRINE More therapies…

    Learn about Your Condition

    Haemofiltration Anogenital warts Dilated cardiomyopathy Device related infection Hypotension Tympanic membrane perforation Necrotising myositis Naevoid melanoma Angiosarcoma metastatic Skin bacterial infection Adrenal insufficiency Head and neck cancer stage III Antithrombin III deficiency Hypothyroidism Pyelonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on the Effects of Fibrin Matrix on Eye Health in Glaucoma Patients Using Long-Term Eye Pressure Medications

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Glaucoma
    Spain

  • Study Comparing Laser Treatment and Tafluprost Eye Drops for Patients with Exfoliation Glaucoma or Ocular Hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Tafluprost
    Finland

  • Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • VRDN-003
    Germany Hungary The Netherlands Poland Spain

  • Study on the Use of PRGF and Hypromellose Eye Drops for Treating Dry Eye Disease in Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Dry eye
    Investigated Drugs:
    • Platelet Concentrate
    • Hypromellose
    • Sodium Chloride
    Spain

  • Study on the Safety and Effectiveness of AGTC-501 for Men with X-linked Retinitis Pigmentosa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinitis pigmentosa
    Investigated Drugs:
    • Adeno-Associated Virus Vector Containing The Human Rpgr Gene
    • Brinzolamide
    • Dorzolamide
    Spain

  • Study of Darovasertib and Crizotinib for Patients with HLA-A2 Negative Metastatic Uveal Melanoma

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Dacarbazine
    • Darovasertib
    • Crizotinib
    Belgium
Previous Page
1 … 15 16 17 18 19 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!